Suppliers / Nantong Noatic Bio-Pharm Technology

Nantong Noatic Bio-Pharm Technology

China Updated 9 July 2026

Nantong Noatic Bio-Pharm Technology is an API manufacturer based in China. It holds 5 active US drug master files across a filed portfolio of 2 molecules.

5
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Lenacapavir US FDA 4
Semaglutide US FDA 1

Also appears on these molecule pages

Exatecan contract manufacturing Lenacapavir contract manufacturing Orforglipron contract manufacturing Semaglutide API

Questions about Nantong Noatic Bio-Pharm Technology

Does Nantong Noatic Bio-Pharm Technology hold a US DMF or a CEP?
Nantong Noatic Bio-Pharm Technology holds 5 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Nantong Noatic Bio-Pharm Technology make?
2 molecules are on record against Nantong Noatic Bio-Pharm Technology, including Lenacapavir and Semaglutide. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Nantong Noatic Bio-Pharm Technology comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hetero shares 1 molecule Cipla shares 1 molecule Lee Pharma shares 1 molecule Shandong Cheminspire Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability